Compare Intiland Development Tbk. (DILD) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intiland Development Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Intiland Development Tbk. trades at Rp114 (market cap 1.2T, 13.47M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Intiland Development Tbk. is the larger of the two by market cap, and Intiland Development Tbk. is more actively traded (13.47M versus 843K). Which is the better fit depends on your goals.
| DILD | LABS | |
|---|---|---|
Market Cap | 1.2T | 635.95B |
Volume | 13.47M | 843K |
Lot | 134.73K | 8.43K |
Turnover | 1.54B | 137.6M |
Average Price | 114.29 | 163.22 |
Value | 1.54B | 137.6M |
Indicative Equilibrium Price | 114 | 165 |
Indicative Equilibrium Volume | 146 | 246 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intiland Development Tbk.
PT Intiland Development Tbk formerly Dharmala Intiland, controlled by the Gondokusumo family, was established in 1983 as the property arm of the Dharmala Group. The company is basically a real estate developer with its principal asset being the 240-hectare Grande Family Estate in Surabaya.
Read more on DILD →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
